Nurix Therapeutics, Inc. (NRIX)
15.49
-0.15
(-0.96%)
USD |
NASDAQ |
Feb 18, 16:00
15.75
+0.26
(+1.68%)
After-Hours: 17:39
Nurix Therapeutics Market Cap : 1.593B for Feb. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 83.74B |
| Incyte Corp. | 20.49B |
| Madrigal Pharmaceuticals, Inc. | 11.19B |
| SELLAS Life Sciences Group, Inc. | 645.37M |
| Arcturus Therapeutics Holdings, Inc. | 213.11M |
Market Cap Related Metrics
| PS Ratio | 15.99 |
| PEG Ratio | -0.9655 |
| Price to Book Value | 2.957 |
| Price | 15.49 |
| Earnings Yield | -19.64% |
| PEGY Ratio | -0.9655 |